ANAB - ANAPTYSBIO, INC
64.67
2.660 4.113%
Share volume: 901,628
Last Updated: 03-11-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$62.01
2.66
0.04%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-05-2024 | 11-05-2024 | 02-27-2025 | 05-05-2025 | 08-06-2025 | 11-04-2025 | 03-03-2026 | |
| Cash flow financing | -13.633 M | 41.890 M | 71.230 M | 27.567 M | -28.590 M | -50.498 M | -10.391 M | -43.134 M | |
| Other financing cash flows | -14.444 M | 40.947 M | 67.539 M | 27.487 M | -24.456 M | -823.000 K | -1.007 M | -51.962 M | |
| Cash flow | 17.730 M | 18.126 M | 119.760 M | -68.501 M | -24.443 M | -54.339 M | 65.535 M | 128.363 M | |
| Net income | -43.936 M | -46.660 M | -32.851 M | -21.784 M | -39.329 M | -38.630 M | 15.113 M | 49.614 M | |
| Depreciation | 163.000 K | 154.000 K | 144.000 K | 145.000 K | 146.000 K | 142.000 K | 140.000 K | 131.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 68.616 M | -2.442 M | 58.620 M | -29.396 M | 14.847 M | 36.403 M | 103.282 M | 73.500 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 27.000 K | 33.000 K | 35.000 K | 263.000 K | 35.000 K | 39.000 K | 12.000 K | 1.000 K | |
| Cash Change | 17.730 M | 18.126 M | 119.760 M | -68.501 M | -24.443 M | -54.339 M | 65.535 M | 128.363 M |